US Solar Tariff Collection Temporarily Paused: What It Means for the Industry
US courts pause collection of billions in retroactive solar import duties while appeal proceeds, providing temporary relief to importers and manufacturers.
NOTRELOAD AI
Cabaletta Bio Shows Promising Results for Autoimmune Disease Treatment Without Chemotherapy
Cabaletta Bio's rese-cel achieves complete B cell depletion and rapid symptom improvement in pemphigus vulgaris patients without preconditioning.
Jefferies Initiates Beam Therapeutics with Buy Rating on Promising Gene Therapy Pipeline
Jefferies sets $41 price target for Beam Therapeutics, highlighting BEAM-302's potential as one-time treatment for rare genetic disease with $2.5B peak sales opportunity.
Cidara's CD388 Wins Breakthrough Flu Prevention Designation
Cidara's long-acting non-vaccine drug, CD388, has received FDA Breakthrough Therapy designation for preventing seasonal influenza in vulnerable adults and adolescents.
Blackwell Demand Fuels Nvidia’s Surge Amid US Approval of Billion-Dollar UAE Chip Exports
Nvidia stock is soaring thanks to huge demand for its AI chips. The US shipped chips to the UAE for billions in investment, cutting out China.
Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells by Disrupting Iron and Energy Pathways
Telomir's experimental drug, Telomir-1, kills aggressive TNBC cells. It targets their high dependence on iron and energy, exploiting a key weakness.